Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.
Don W CoulterYashpal S ChhonkerDevendra KumarVarun KesherwaniWafaa N AldhafiriErin M McIntyreGracey AlexanderSutapa RayShantaram S JoshiRongshi LiDaryl J MurryNagendra K ChaturvediPublished in: Journal of experimental & clinical cancer research : CR (2024)
These preclinical findings highlight the promise of marinopyrrole MP1 as a novel MYC inhibition approach for MYC-amplified MB.